Search company, investor...

QuantomiX

wetsem.com

Founded Year

2001

Stage

Other Investors | Alive

About QuantomiX

QuantomiX develops products for rapid, high resolution imaging of wet samples.The company was founded in 2001 to commercialize its technology which, for a time, aims to enable direct imaging of fully hydrated samples in an electron microscope.With the Quantomix QXTM capsule product line, wet samples, including cells and tissues, can now be examined without any of the conventional treatments such as drying, deep freezing and sectioning. This opens the way to a better understanding of biomedical processes, to improved patient care, and to more effective pharmaceutical research.The QXTM capsules, that fit any Scanning Electron Microscope (SEM), close the resolution gap between conventional electron microscopy and light microscopy. They offer the convenient sample preparation of light microscopy.

Headquarters Location

Weizmann Science Park 12 Hamada st.

Israel

Missing: QuantomiX's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: QuantomiX's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

QuantomiX Patents

QuantomiX has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/11/2007

8/11/2009

Electron microscopy, Transcription factors, Microscopy, Clusters of differentiation, Proteins

Grant

Application Date

5/11/2007

Grant Date

8/11/2009

Title

Related Topics

Electron microscopy, Transcription factors, Microscopy, Clusters of differentiation, Proteins

Status

Grant

QuantomiX Frequently Asked Questions (FAQ)

  • When was QuantomiX founded?

    QuantomiX was founded in 2001.

  • What is QuantomiX's latest funding round?

    QuantomiX's latest funding round is Other Investors.

  • Who are the investors of QuantomiX?

    Investors of QuantomiX include Pitango Venture Capital.

  • Who are QuantomiX's competitors?

    Competitors of QuantomiX include Optovue, Orthoscan, InPhenix, Celsense, Infrascan and 12 more.

Compare QuantomiX to Competitors

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

H
Huron Digital Pathology

Huron Digital Pathology, previously known as Biomedical Photometrics, aims to provide panoramic confocal scanning laser microscopes for the pathology, medical research, genomics, and general microscopy markets.

N
Neurognostics

Neurognostics is engaged in the commercialization of functional Magnetic Resonance Imaging (fMRI) technologies for early diagnosis of central nervous system (CNS) disorders and support of new pharmaceutical therapeutic development.

I
InstaRecon

InstaRecon is a groundbreaking imaging technology company that aims to provide image formation solutions for computer tomography that have unparalleled speed. Image formation in the latest medical CT scanners lags data acquisition by a factor of 20. The speedups provided by InstaRecon are needed to overcome the computational bottleneck, enabling new features of real-time imaging, improved image quality, and reduced radiation-dose imaging, at reduced costs.

Ultraspect Logo
Ultraspect

ULTRASPECT specializes in the development, production and sale of products dedicated to the enhancement of imaging quality and productivity performance of NM Gamma Cameras. Based on its , reconstruction algorithms technology, Wide-Beam Reconstruction (WBRTM), the company's imaging solutions shorten acquisition times and increase image resolution.

M
MicroMRI

MicroMRI has developed an method to visualize bone micro-architecture using high resolution MRI. MicroMRI's product is post-processing software that converts MRI images into three-dimensional display of bone microarchitecture with the possibility of manual or automated measurements. MicroMRI can also provide a dedicated coil for high-resolution MR imaging of the wrist. Clinical investigators have used MicroMRI's post-processing software in combination with a modified spin echo pulse sequence called FLASE (Fast Large Angle Spin Echo).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.